ABCB1 (MDR1)-Type P-Glycoproteins at the Blood–Brain Barrier Modulate the Activity of the Hypothalamic–Pituitary–Adrenocortical System: Implications for Affective Disorder
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Multidrug-resistance gene 1-type P-glycoproteins (ABCB1-type P-gps) protect the brain against the accumulation of many toxic xenobiotics and drugs. We recently could show that the access of the endogenous glucocorticoids corticosterone and cortisol to the brain are regulated by ABCB1-type P-gps in vivo. ABCB1-type P-gp function, therefore, is likely to exert a profound influence on the regulation of the hypothalamic-pituitary-adrenocortical (HPA) system. Hyperactivity of the HPA system is frequently observed in human affective disorder, and a considerable amount of evidence has been accumulated suggesting that normalization of the HPA system might be the final step necessary for stable remission of the disease. To examine whether blood-brain barrier (BBB) function influences neuroendocrine regulation, we investigated HPA system activity in abcb1ab (-/-) mice under basal conditions and following stress. Abcb1ab (-/-) mice showed consistently lower plasma ACTH levels and lower evening plasma corticosterone levels. CRH mRNA expression in the hypothalamic paraventricular nucleus was decreased and pituitary POMC mRNA expressing cells were significantly reduced in number in abcb1ab (-/-) mutants; however, they showed a normal activation of the HPA system following CRH stimulation. Lower doses of dexamethasone were required to suppress plasma corticosterone levels in mutants. Our data thus provide evidence for a sustained suppression of the HPA system at the hypothalamic level in abcb1ab (-/-) mice, suggesting that BBB function significantly regulates HPA system activity. Whether naturally occurring polymorphisms in the human ABCB1 gene might result in persistent changes in the responsiveness and regulation of the HPA system will be the subject of future investigations, correlating both genetic information with individual characteristics of the neuroendocrine phenotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965 · cited 1×
“CRH stimulates the immediate release of POMC-derived peptides in the pituitary gland (Vale et al, 1981), and is the main positive physiological regulator of POMC gene transcription in anterior pituitary corticotropes both in vitro and in vivo (Gagner and Drouin, 1987; Jin et al, 1994).”
BackgroundBrain corticosteroid receptor balance in health and disease
de Kloet, E. R., Vreugdenhil, E., Oitzl, M. S., & Joëls, M. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.3.0331 · Cited by 2,614 · cited 2×
“Neuropsychopharmacology system is restrained during stress and activity (for a review, see de Kloet et al, 1998).”
BackgroundBrain corticosteroid receptor balance in health and disease
de Kloet, E. R. (1998) · Endocrine Reviews · doi:10.1210/er.19.3.269 · Cited by 2,614
The Corticosteroid Receptor Hypothesis of Depression
Holsboer, F. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00159-7 · Cited by 2,181
Self-citationGlucocorticoid receptors in major depression: relevance to pathophysiology and treatment
Pariante, C. M., & Miller, A. H. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01088-x · Cited by 1,147 · cited 3×
“Impairment of corticosteroid receptor signaling and feedback inhibition, in particular, has been suggested to play a key role in the development of neuroendocrine changes associated with human affective disorders (Holsboer, 2000; Pariante and Miller, 2001; Müller et al, 2002).”
BackgroundProlonged glucocorticoid exposure reduces hippocampal neuron number: implications for aging
Sapolsky, R., Krey, L., & McEwen, B. (1985) · The Journal of Neuroscience · doi:10.1523/jneurosci.05-05-01222.1985 · Cited by 1,129 · cited 1×
“…structural alterations, revealed no evidence of any major hippocampal cell death or damage due to elevated plasma glucocorticoid levels (Lucassen et al, 2001; Müller et al, 2001a), as described following prolonged and fatal stress in nonhuman primates (Sapolsky et al, 1985; Uno et al, 1989).”
BackgroundInfluentialMeaney, M. J., Diorio, J., Francis, D., Widdowson, J., LaPlante, P., Caldji, C., Sharma, S., Seckl, J. R., & Plotsky, P. M. (2010) · Developmental Neuroscience · doi:10.1159/000111395 · Cited by 878
Hippocampal damage associated with prolonged and fatal stress in primates
Uno, H., Tarara, R., Else, J., Suleman, M., & Sapolsky, R. (1989) · The Journal of Neuroscience · doi:10.1523/jneurosci.09-05-01705.1989 · Cited by 728 · cited 1×
“…structural alterations, revealed no evidence of any major hippocampal cell death or damage due to elevated plasma glucocorticoid levels (Lucassen et al, 2001; Müller et al, 2001a), as described following prolonged and fatal stress in nonhuman primates (Sapolsky et al, 1985; Uno et al, 1989).”
BackgroundInfluentialRaadsheer, F. C., Hoogendijk, W. J. G., Stam, F. C., Tilders, F. J. H., & Swaab, D. F. (2008) · Neuroendocrinology · doi:10.1159/000126778 · Cited by 667
The combined dexamethasone/CRH test: A refined laboratory test for psychiatric disorders
Heuser, I., Yassouridis, A., & Holsboer, F. (1994) · Journal of Psychiatric Research · doi:10.1016/0022-3956(94)90017-5 · Cited by 662
Self-citationHolsboer, F. (1999) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(98)90056-5 · Cited by 654 · cited 1×
“…of the HPA system is observed in a substantial percentage of depressed patients, and a considerable amount of evidence has been accumulated suggesting that normalization of the HPA system might be the final step necessary for stable remission of the disease (for a review, see Holsboer, 1999, 2000).”
BackgroundSelf-citationCorticosteroids in relation to fear, anxiety and psychopathology
Korte, S. M. (2001) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(01)00002-1 · Cited by 607 · cited 1×
“In addition, corticosteroids play extremely important roles in modulating fear and anxiety-related behavior (Korte, 2001).”
BackgroundMüller, M. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00099-3 · Cited by 292 · cited 3×
“Quantitative analysis of mRNA expression was performed blind to the animals’ genotype as previously described (Müller et al, 2000b), using the Macintosh-based public domain image analysis program NIH image, version 1.6.1.”
MethodInfluentialSelf-citationMüller, M. B., Lucassen, P. J., Yassouridis, A., Hoogendijk, W. J. G., Holsboer, F., & Swaab, D. F. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01784.x · Cited by 249
Self-citationCorticosteroid Receptor Function Is Decreased in Depressed Patients
Modell, S., Yassouridis, A., Huber, J., & Holsboer, F. (2008) · Neuroendocrinology · doi:10.1159/000127275 · Cited by 204
Self-citationFink, G., Robinson, I. C., & Tannahill, L. A. (1988) · The Journal of Physiology · doi:10.1113/jphysiol.1988.sp017165 · Cited by 121 · cited 1×
“Whether in the presence of ABCB1-type P-gp the synthetic glucocorticoid dexamethasone penetrates the BBB at biologically significant concentrations has been the subject of controversy (Fink et al, 1988; Meijer et al, 1998; Pariante et al, 2002).”
BackgroundBrunson, K. L., Avishai-Eliner, S., Hatalski, C. G., & Baram, T. Z. (2001) · Molecular Psychiatry · doi:10.1038/sj.mp.4000942 · Cited by 112 · cited 1×
“Genetic variability of the ABCB1 gene, therefore, may alter an innate setpoint for susceptibility to stress-associated psychiatric disorders (Meaney et al, 1996; Brunson et al, 2001).”
BackgroundPariante, C. M., Hye, A., Williamson, R., Makoff, A., Lovestone, S., & Kerwin, R. W. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300195 · Cited by 70 · cited 2×
“Such variability could be either druginduced (Schinkel et al, 1996; Doze et al, 2000; Pariante et al, 2003) or ABCB1-type P-gp function could be altered under certain pathophysiological conditions.”
Background
Cited by
Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases
Löscher, W., & Potschka, H. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.04.006 · Cited by 617
Pluronics and MDR reversal: an update
Alakhova, D. Y., & Kabanov, A. V. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500298q · Cited by 224
Do antidepressants regulate how cortisol affects the brain?
Pariante, C. M., Thomas, S. A., Lovestone, S., Makoff, A., & Kerwin, R. W. (2004) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2003.10.009 · Cited by 194
The glucocorticoid receptor: part of the solution or part of the problem?
Pariante, C. M. (2006) · Journal of Psychopharmacology · doi:10.1177/1359786806066063 · Cited by 192
Cao, N., & Feng, S.-S. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.05.016 · Cited by 179
Metadata
- Authors
- Müller, M. B., Keck, M. E., Binder, E. B., Kresse, A. E., Hagemeyer, T. P., Landgraf, R., Holsboer, F., & Uhr, M.
- Venue
- Neuropsychopharmacology
- Published
- 2003-06-04
- Volume
- 28
- Issue
- 11
- Pages
- 1991-1999
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2023350482
- Cited by
- 86
- References
- 18
- FWCI
- 2.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.